The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Soluble CD87 (s-uPAR) predicts bevacizumab-based first line treatment of metastatic colorectal cancer (mCRC): Results from a prospective multi-center study.
 
Matthias Unseld
Travel, Accommodations, Expenses - Merck
 
Gabriele Kornek
No Relationships to Disclose
 
Andreas Gleiss
No Relationships to Disclose
 
Svitlana Demyantes
No Relationships to Disclose
 
Jost Schwarzwald
No Relationships to Disclose
 
Daniela Bianconi
No Relationships to Disclose
 
Johannes Andel
No Relationships to Disclose
 
Christoph Tinchon
No Relationships to Disclose
 
Martin Pecherstorfer
No Relationships to Disclose
 
Wolfgang Eisterer
No Relationships to Disclose
 
Björn Jagdt
No Relationships to Disclose
 
Andreas Kretschmer
No Relationships to Disclose
 
Armin Gerger
No Relationships to Disclose
 
Richard Greil
No Relationships to Disclose
 
Adelheid Seebacher
No Relationships to Disclose
 
Peter Krippl
No Relationships to Disclose
 
Friedrich Laengle
No Relationships to Disclose
 
Christoph Zielinski
Honoraria - Roche
Consulting or Advisory Role - Roche
 
Werner Scheithauer
Consulting or Advisory Role - Bayer; Roche
Research Funding - Roche
 
Gerald W. Prager
Consulting or Advisory Role - Bayer; Celgene; Roche
Research Funding - Bayer